nodes	percent_of_prediction	percent_of_DWPC	metapath
Homatropine Methylbromide—CHRM3—ureter—prostate cancer	0.171	0.535	CbGeAlD
Homatropine Methylbromide—CHRM5—epithelium—prostate cancer	0.0262	0.082	CbGeAlD
Homatropine Methylbromide—CHRM2—prostate gland—prostate cancer	0.0245	0.0766	CbGeAlD
Homatropine Methylbromide—CHRM1—prostate gland—prostate cancer	0.0223	0.0697	CbGeAlD
Homatropine Methylbromide—CHRM4—testis—prostate cancer	0.0201	0.0629	CbGeAlD
Homatropine Methylbromide—CHRM3—prostate gland—prostate cancer	0.0199	0.0624	CbGeAlD
Homatropine Methylbromide—CHRM3—renal system—prostate cancer	0.0136	0.0425	CbGeAlD
Homatropine Methylbromide—CHRM3—urethra—prostate cancer	0.0134	0.0418	CbGeAlD
Homatropine Methylbromide—CHRM3—testis—prostate cancer	0.00879	0.0275	CbGeAlD
Homatropine Methylbromide—CHRM1—Signaling Pathways—ITGB3—prostate cancer	8.67e-05	0.000127	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—KRAS—prostate cancer	8.67e-05	0.000127	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—ITGB3—prostate cancer	8.64e-05	0.000127	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—ITGB3—prostate cancer	8.56e-05	0.000126	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—MAP2K1—prostate cancer	8.53e-05	0.000125	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—PIK3CD—prostate cancer	8.48e-05	0.000125	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—FGF2—prostate cancer	8.47e-05	0.000125	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	8.46e-05	0.000124	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	8.43e-05	0.000124	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—ERBB3—prostate cancer	8.41e-05	0.000124	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—PIK3CA—prostate cancer	8.4e-05	0.000123	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—FGFR2—prostate cancer	8.39e-05	0.000123	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—SERPINE1—prostate cancer	8.38e-05	0.000123	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—ERBB3—prostate cancer	8.38e-05	0.000123	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—FGFR2—prostate cancer	8.37e-05	0.000123	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—NOS3—prostate cancer	8.36e-05	0.000123	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	8.35e-05	0.000123	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—ERBB3—prostate cancer	8.3e-05	0.000122	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—KRAS—prostate cancer	8.3e-05	0.000122	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—FGFR2—prostate cancer	8.29e-05	0.000122	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—JAK2—prostate cancer	8.12e-05	0.000119	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—FGF2—prostate cancer	8.12e-05	0.000119	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PIK3CG—prostate cancer	8.09e-05	0.000119	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—IL2—prostate cancer	8.09e-05	0.000119	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—IL2—prostate cancer	8.06e-05	0.000118	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TERT—prostate cancer	8.06e-05	0.000118	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TERT—prostate cancer	8.03e-05	0.000118	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—NOS3—prostate cancer	8e-05	0.000118	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—IL2—prostate cancer	7.98e-05	0.000117	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—PIK3CA—prostate cancer	7.96e-05	0.000117	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TERT—prostate cancer	7.95e-05	0.000117	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—MDM2—prostate cancer	7.93e-05	0.000117	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—ERBB2—prostate cancer	7.82e-05	0.000115	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—JAK2—prostate cancer	7.78e-05	0.000114	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—PIK3CB—prostate cancer	7.71e-05	0.000113	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—HIF1A—prostate cancer	7.71e-05	0.000113	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—HIF1A—prostate cancer	7.68e-05	0.000113	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—INS—prostate cancer	7.66e-05	0.000113	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—PIK3CA—prostate cancer	7.62e-05	0.000112	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—HIF1A—prostate cancer	7.61e-05	0.000112	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—MDM2—prostate cancer	7.59e-05	0.000112	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—LEP—prostate cancer	7.52e-05	0.000111	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—CREBBP—prostate cancer	7.5e-05	0.00011	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—LEP—prostate cancer	7.5e-05	0.00011	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—ERBB2—prostate cancer	7.49e-05	0.00011	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CAV1—prostate cancer	7.45e-05	0.00011	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CAV1—prostate cancer	7.43e-05	0.000109	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—LEP—prostate cancer	7.43e-05	0.000109	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CXCL8—prostate cancer	7.41e-05	0.000109	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—PIK3CB—prostate cancer	7.39e-05	0.000109	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—KDR—prostate cancer	7.37e-05	0.000108	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CAV1—prostate cancer	7.36e-05	0.000108	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—KDR—prostate cancer	7.35e-05	0.000108	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—KDR—prostate cancer	7.27e-05	0.000107	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CDKN1B—prostate cancer	7.24e-05	0.000106	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—ESR1—prostate cancer	7.18e-05	0.000106	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—GPCR downstream signaling—AKT1—prostate cancer	7.16e-05	0.000105	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—ESR1—prostate cancer	7.16e-05	0.000105	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PIK3CD—prostate cancer	7.11e-05	0.000105	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CXCL8—prostate cancer	7.1e-05	0.000104	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CASP3—prostate cancer	7.1e-05	0.000104	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—ESR1—prostate cancer	7.09e-05	0.000104	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IL2—prostate cancer	7.08e-05	0.000104	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—IL6—prostate cancer	7.05e-05	0.000104	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—BAD—prostate cancer	7.01e-05	0.000103	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—BAD—prostate cancer	6.99e-05	0.000103	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CDKN1B—prostate cancer	6.93e-05	0.000102	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—BAD—prostate cancer	6.92e-05	0.000102	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CCND1—prostate cancer	6.91e-05	0.000102	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—GPCR downstream signaling—AKT1—prostate cancer	6.86e-05	0.000101	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CTNNB1—prostate cancer	6.84e-05	0.000101	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CASP3—prostate cancer	6.79e-05	9.99e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	6.79e-05	9.98e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—APC—prostate cancer	6.79e-05	9.98e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IL2—prostate cancer	6.78e-05	9.97e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	6.77e-05	9.95e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—APC—prostate cancer	6.77e-05	9.95e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—IL6—prostate cancer	6.75e-05	9.92e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—NOS3—prostate cancer	6.72e-05	9.88e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—EGF—prostate cancer	6.71e-05	9.86e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IRS1—prostate cancer	6.71e-05	9.86e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—MMP9—prostate cancer	6.71e-05	9.86e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—APC—prostate cancer	6.7e-05	9.85e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	6.7e-05	9.85e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IRS1—prostate cancer	6.69e-05	9.83e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—EGF—prostate cancer	6.69e-05	9.83e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—CDKN1A—prostate cancer	6.68e-05	9.82e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—PTEN—prostate cancer	6.67e-05	9.8e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—EGF—prostate cancer	6.62e-05	9.74e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IRS1—prostate cancer	6.62e-05	9.74e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CCND1—prostate cancer	6.61e-05	9.72e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CTNNB1—prostate cancer	6.55e-05	9.63e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—GSK3B—prostate cancer	6.51e-05	9.58e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling by GPCR—AKT1—prostate cancer	6.5e-05	9.56e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—GSK3B—prostate cancer	6.49e-05	9.55e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—GSK3B—prostate cancer	6.43e-05	9.45e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—INS—prostate cancer	6.43e-05	9.45e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—MMP9—prostate cancer	6.42e-05	9.44e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—INS—prostate cancer	6.41e-05	9.42e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—CDKN1A—prostate cancer	6.4e-05	9.41e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—PTEN—prostate cancer	6.38e-05	9.38e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—EP300—prostate cancer	6.36e-05	9.35e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—INS—prostate cancer	6.34e-05	9.32e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CREBBP—prostate cancer	6.29e-05	9.25e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CREBBP—prostate cancer	6.27e-05	9.22e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling by GPCR—AKT1—prostate cancer	6.23e-05	9.15e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IGF1—prostate cancer	6.22e-05	9.14e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CREBBP—prostate cancer	6.21e-05	9.13e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PIK3CB—prostate cancer	6.2e-05	9.12e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IGF1—prostate cancer	6.2e-05	9.11e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—EGFR—prostate cancer	6.18e-05	9.09e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—SRC—prostate cancer	6.18e-05	9.09e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—EGFR—prostate cancer	6.17e-05	9.06e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PTGS2—prostate cancer	6.14e-05	9.03e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IGF1—prostate cancer	6.14e-05	9.02e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—EGFR—prostate cancer	6.11e-05	8.97e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—EP300—prostate cancer	6.09e-05	8.95e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—VEGFA—prostate cancer	6.02e-05	8.85e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	6.01e-05	8.83e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	5.99e-05	8.8e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	5.97e-05	8.77e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—STAT3—prostate cancer	5.96e-05	8.76e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	5.95e-05	8.74e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	5.93e-05	8.72e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—SRC—prostate cancer	5.92e-05	8.7e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	5.91e-05	8.69e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	5.9e-05	8.68e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	5.89e-05	8.66e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	5.89e-05	8.66e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	5.88e-05	8.65e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—KRAS—prostate cancer	5.84e-05	8.59e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	5.84e-05	8.58e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	5.83e-05	8.57e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—KRAS—prostate cancer	5.82e-05	8.56e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—KRAS—prostate cancer	5.77e-05	8.48e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—VEGFA—prostate cancer	5.77e-05	8.48e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—FGF2—prostate cancer	5.71e-05	8.4e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—STAT3—prostate cancer	5.71e-05	8.39e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—FGF2—prostate cancer	5.7e-05	8.37e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—FGF2—prostate cancer	5.64e-05	8.29e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—NOS3—prostate cancer	5.64e-05	8.28e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—NOS3—prostate cancer	5.62e-05	8.26e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—NOS3—prostate cancer	5.56e-05	8.18e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—MYC—prostate cancer	5.54e-05	8.14e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—TGFB1—prostate cancer	5.53e-05	8.12e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—JAK2—prostate cancer	5.48e-05	8.05e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—JAK2—prostate cancer	5.46e-05	8.03e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—EGFR—prostate cancer	5.42e-05	7.97e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—JAK2—prostate cancer	5.41e-05	7.95e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	5.37e-05	7.89e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PTEN—prostate cancer	5.36e-05	7.88e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	5.35e-05	7.87e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—MDM2—prostate cancer	5.35e-05	7.86e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—MDM2—prostate cancer	5.33e-05	7.83e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—MYC—prostate cancer	5.31e-05	7.8e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	5.3e-05	7.79e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—TGFB1—prostate cancer	5.29e-05	7.78e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—MDM2—prostate cancer	5.28e-05	7.76e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—ERBB2—prostate cancer	5.27e-05	7.75e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—ERBB2—prostate cancer	5.25e-05	7.72e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—ERBB2—prostate cancer	5.2e-05	7.65e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	5.2e-05	7.65e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—EGFR—prostate cancer	5.19e-05	7.63e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	5.19e-05	7.62e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	5.13e-05	7.55e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—KRAS—prostate cancer	5.12e-05	7.52e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—EP300—prostate cancer	5.11e-05	7.51e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CXCL8—prostate cancer	5e-05	7.35e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CXCL8—prostate cancer	4.98e-05	7.32e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CXCL8—prostate cancer	4.93e-05	7.25e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—KRAS—prostate cancer	4.9e-05	7.21e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	4.88e-05	7.18e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	4.87e-05	7.15e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	4.83e-05	7.1e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	4.82e-05	7.08e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	4.81e-05	7.08e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CASP3—prostate cancer	4.78e-05	7.03e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IL2—prostate cancer	4.78e-05	7.02e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CASP3—prostate cancer	4.77e-05	7.01e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	4.77e-05	7.01e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IL2—prostate cancer	4.76e-05	7e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—IL6—prostate cancer	4.75e-05	6.99e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—IL6—prostate cancer	4.74e-05	6.97e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CASP3—prostate cancer	4.72e-05	6.94e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IL2—prostate cancer	4.72e-05	6.93e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—PIK3CA—prostate cancer	4.7e-05	6.91e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—IL6—prostate cancer	4.69e-05	6.9e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CCND1—prostate cancer	4.66e-05	6.85e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CCND1—prostate cancer	4.64e-05	6.82e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	4.61e-05	6.78e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	4.6e-05	6.76e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CCND1—prostate cancer	4.6e-05	6.76e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	4.55e-05	6.69e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—TP53—prostate cancer	4.55e-05	6.69e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—MMP9—prostate cancer	4.52e-05	6.65e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—MMP9—prostate cancer	4.51e-05	6.63e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	4.51e-05	6.62e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—PIK3CA—prostate cancer	4.5e-05	6.62e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—PTEN—prostate cancer	4.49e-05	6.61e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	4.49e-05	6.6e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—PTEN—prostate cancer	4.48e-05	6.59e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—MMP9—prostate cancer	4.46e-05	6.56e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	4.45e-05	6.54e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—PTEN—prostate cancer	4.44e-05	6.52e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling by GPCR—AKT1—prostate cancer	4.39e-05	6.45e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling by GPCR—AKT1—prostate cancer	4.37e-05	6.43e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—TP53—prostate cancer	4.36e-05	6.4e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling by GPCR—AKT1—prostate cancer	4.33e-05	6.36e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—EP300—prostate cancer	4.29e-05	6.3e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—EP300—prostate cancer	4.27e-05	6.28e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—EP300—prostate cancer	4.23e-05	6.22e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—SRC—prostate cancer	4.17e-05	6.13e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—IL6—prostate cancer	4.16e-05	6.12e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—SRC—prostate cancer	4.16e-05	6.11e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—SRC—prostate cancer	4.11e-05	6.05e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—VEGFA—prostate cancer	4.06e-05	5.97e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—VEGFA—prostate cancer	4.05e-05	5.95e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—STAT3—prostate cancer	4.02e-05	5.91e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—VEGFA—prostate cancer	4.01e-05	5.89e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—STAT3—prostate cancer	4.01e-05	5.89e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—IL6—prostate cancer	3.99e-05	5.86e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—STAT3—prostate cancer	3.97e-05	5.83e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM4—Signaling Pathways—AKT1—prostate cancer	3.84e-05	5.65e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—PIK3CA—prostate cancer	3.78e-05	5.56e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—MYC—prostate cancer	3.74e-05	5.49e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TGFB1—prostate cancer	3.73e-05	5.48e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—MYC—prostate cancer	3.72e-05	5.47e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TGFB1—prostate cancer	3.71e-05	5.46e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—MYC—prostate cancer	3.69e-05	5.42e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM5—Signaling Pathways—AKT1—prostate cancer	3.68e-05	5.41e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TGFB1—prostate cancer	3.68e-05	5.41e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—EGFR—prostate cancer	3.65e-05	5.37e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—EGFR—prostate cancer	3.64e-05	5.35e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—EGFR—prostate cancer	3.61e-05	5.3e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—KRAS—prostate cancer	3.45e-05	5.07e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—KRAS—prostate cancer	3.44e-05	5.06e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—KRAS—prostate cancer	3.41e-05	5.01e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	3.17e-05	4.66e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	3.16e-05	4.65e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	3.13e-05	4.6e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Metabolism—AKT1—prostate cancer	3.09e-05	4.54e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—TP53—prostate cancer	3.07e-05	4.51e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—TP53—prostate cancer	3.06e-05	4.5e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—TP53—prostate cancer	3.03e-05	4.45e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—IL6—prostate cancer	2.81e-05	4.13e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—IL6—prostate cancer	2.8e-05	4.11e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—IL6—prostate cancer	2.77e-05	4.07e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM1—Signaling Pathways—AKT1—prostate cancer	2.59e-05	3.81e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM3—Signaling Pathways—AKT1—prostate cancer	2.58e-05	3.8e-05	CbGpPWpGaD
Homatropine Methylbromide—CHRM2—Signaling Pathways—AKT1—prostate cancer	2.56e-05	3.76e-05	CbGpPWpGaD
